332.20001 EUR
6.2
1.83%
Last update Dec 16, 6:35 PM CET
Market closed
Day range
332.10001
333.70001
Previous close
338.39999
Open
332.10001
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
332.20
6.20
1.83%

Statistics

Valuation metrics
Market cap
0
Enterprise value
280.92M
Trailing P/E (ttm)
-152.39
Forward P/E
PEG ratio
Price/Sales (ttm)
0
Price/Book (mrq)
Enterprise Value/Revenue
0.15
Enterprise Value/EBITDA
-65.21
Overview
Shares outstanding
131.79M
Float
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
2
Average volume (90 days)
1
Price summary
52-Week low
187.50
52-Week high
424
52-Week change
30.04 16.0%
Beta
50-Day moving average
389.27
200-Day moving average
316.84
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
85.62%
Operating margin
-10.48%
Operational effectiveness
Return on assets
-6.56%
Return on equity
-414.62%
Income statement
Revenue (ttm)
1.92B
Revenue per share (ttm)
17.61
Quarterly revenue growth (yoy)
61.44%
Gross profit (ttm)
1.64B
EBITDA
0
Net income to common (ttm)
-237.06M
Diluted EPS (ttm)
-2.18
Quarterly earnings growth (yoy)
145.81%
Balance sheet
Total cash (mrq)
0
Total cash per share (mrq)
Total debt (mrq)
1.12B
Total Debt/Equity (mrq)
5.59
Current ratio (mrq)
254.12%
Book value per share (mrq)
Cash flow
Cash flow statement
-157.95M
Levered free cash flow (LFCF)
-200.53M
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 43 minutes

07:16
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).